Corpus
PascalFrancis
Racine
Corpus
Checkpoint
PascalFrancis
Racine
PascalFrancis
Exploration
Accueil
Racine
Racine

Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Drug-induced supraglottic dystonia and spasmodic dysphonia

Identifieur interne : 002F27 ( PascalFrancis/Corpus ); précédent : 002F26; suivant : 002F28

Drug-induced supraglottic dystonia and spasmodic dysphonia

Auteurs : J. Warren ; P. Thompson

Source :

RBID : Pascal:99-0010796

Descripteurs français

English descriptors

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

pA  
A01 01  1    @0 0885-3185
A03   1    @0 Mov. disord.
A05       @2 13
A06       @2 6
A08 01  1  ENG  @1 Drug-induced supraglottic dystonia and spasmodic dysphonia
A11 01  1    @1 WARREN (J.)
A11 02  1    @1 THOMPSON (P.)
A14 01      @1 Department of Neurology, Royal Adelaide Hospital @2 Adelaide, South Australia @3 AUS @Z 1 aut. @Z 2 aut.
A20       @1 978-979
A21       @1 1998
A23 01      @0 ENG
A43 01      @1 INIST @2 20953 @5 354000071406360220
A44       @0 0000 @1 © 1999 INIST-CNRS. All rights reserved.
A45       @0 1 ref.
A47 01  1    @0 99-0010796
A60       @1 P
A61       @0 A
A64   1    @0 Movement disorders
A66 01      @0 USA
C02 01  X    @0 002B02U01
C02 02  X    @0 235
C03 01  X  FRE  @0 Dystonie @5 01
C03 01  X  ENG  @0 Dystonia @5 01
C03 01  X  SPA  @0 Distonía @5 01
C03 02  X  FRE  @0 Glotte @5 02
C03 02  X  ENG  @0 Glottis @5 02
C03 02  X  SPA  @0 Glotis @5 02
C03 03  X  FRE  @0 Dysphonie spasmodique @5 04
C03 03  X  ENG  @0 Spastic dysphonia @5 04
C03 03  X  SPA  @0 Disfonía espasmódica @5 04
C03 04  X  FRE  @0 Métoclopramide @2 NK @2 FR @5 07
C03 04  X  ENG  @0 Metoclopramide @2 NK @2 FR @5 07
C03 04  X  SPA  @0 Metoclopramida @2 NK @2 FR @5 07
C03 05  X  FRE  @0 Neuroleptique @5 08
C03 05  X  ENG  @0 Neuroleptic @5 08
C03 05  X  SPA  @0 Neuroléptico @5 08
C03 06  X  FRE  @0 Etude cas @5 16
C03 06  X  ENG  @0 Case study @5 16
C03 06  X  SPA  @0 Estudio caso @5 16
C03 07  X  FRE  @0 Toxicité @5 17
C03 07  X  ENG  @0 Toxicity @5 17
C03 07  X  GER  @0 Giftigkeit @5 17
C03 07  X  SPA  @0 Toxicidad @5 17
C03 08  X  FRE  @0 Personne âgée @5 20
C03 08  X  ENG  @0 Elderly @5 20
C03 08  X  SPA  @0 Anciano @5 20
C03 09  X  FRE  @0 Femelle @5 21
C03 09  X  ENG  @0 Female @5 21
C03 09  X  SPA  @0 Hembra @5 21
C03 10  X  FRE  @0 Chimiothérapie @5 23
C03 10  X  ENG  @0 Chemotherapy @5 23
C03 10  X  SPA  @0 Quimioterapia @5 23
C03 11  X  FRE  @0 Benzamide dérivé @5 29
C03 11  X  ENG  @0 Benzamide derivatives @5 29
C03 11  X  SPA  @0 Benzamida derivado @5 29
C07 01  X  FRE  @0 Homme
C07 01  X  ENG  @0 Human
C07 01  X  SPA  @0 Hombre
C07 02  X  FRE  @0 Muscle strié pathologie @5 37
C07 02  X  ENG  @0 Striated muscle disease @5 37
C07 02  X  SPA  @0 Músculo estriado patología @5 37
C07 03  X  FRE  @0 Système nerveux pathologie @5 38
C07 03  X  ENG  @0 Nervous system diseases @5 38
C07 03  X  SPA  @0 Sistema nervioso patología @5 38
C07 04  X  FRE  @0 Trouble neurologique @5 39
C07 04  X  ENG  @0 Neurological disorder @5 39
C07 04  X  SPA  @0 Trastorno neurológico @5 39
C07 05  X  FRE  @0 Mouvement involontaire @5 40
C07 05  X  ENG  @0 Involuntary movement @5 40
C07 05  X  SPA  @0 Movimiento involuntario @5 40
C07 06  X  FRE  @0 Extrapyramidal syndrome @5 41
C07 06  X  ENG  @0 Extrapyramidal syndrome @5 41
C07 06  X  SPA  @0 Extrapiramidal síndrome @5 41
C07 07  X  FRE  @0 ORL pathologie @5 45
C07 07  X  ENG  @0 ENT disease @5 45
C07 07  X  SPA  @0 ORL patología @5 45
C07 08  X  FRE  @0 Larynx pathologie @5 46
C07 08  X  ENG  @0 Larynx disease @5 46
C07 08  X  SPA  @0 Laringe patología @5 46
N21       @1 004

Format Inist (serveur)

NO : PASCAL 99-0010796 INIST
ET : Drug-induced supraglottic dystonia and spasmodic dysphonia
AU : WARREN (J.); THOMPSON (P.)
AF : Department of Neurology, Royal Adelaide Hospital/Adelaide, South Australia/Australie (1 aut., 2 aut.)
DT : Publication en série; Niveau analytique
SO : Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 1998; Vol. 13; No. 6; Pp. 978-979; Bibl. 1 ref.
LA : Anglais
CC : 002B02U01; 235
FD : Dystonie; Glotte; Dysphonie spasmodique; Métoclopramide; Neuroleptique; Etude cas; Toxicité; Personne âgée; Femelle; Chimiothérapie; Benzamide dérivé
FG : Homme; Muscle strié pathologie; Système nerveux pathologie; Trouble neurologique; Mouvement involontaire; Extrapyramidal syndrome; ORL pathologie; Larynx pathologie
ED : Dystonia; Glottis; Spastic dysphonia; Metoclopramide; Neuroleptic; Case study; Toxicity; Elderly; Female; Chemotherapy; Benzamide derivatives
EG : Human; Striated muscle disease; Nervous system diseases; Neurological disorder; Involuntary movement; Extrapyramidal syndrome; ENT disease; Larynx disease
GD : Giftigkeit
SD : Distonía; Glotis; Disfonía espasmódica; Metoclopramida; Neuroléptico; Estudio caso; Toxicidad; Anciano; Hembra; Quimioterapia; Benzamida derivado
LO : INIST-20953.354000071406360220
ID : 99-0010796

Links to Exploration step

Pascal:99-0010796

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Drug-induced supraglottic dystonia and spasmodic dysphonia</title>
<author>
<name sortKey="Warren, J" sort="Warren, J" uniqKey="Warren J" first="J." last="Warren">J. Warren</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Neurology, Royal Adelaide Hospital</s1>
<s2>Adelaide, South Australia</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Thompson, P" sort="Thompson, P" uniqKey="Thompson P" first="P." last="Thompson">P. Thompson</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Neurology, Royal Adelaide Hospital</s1>
<s2>Adelaide, South Australia</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">99-0010796</idno>
<date when="1998">1998</date>
<idno type="stanalyst">PASCAL 99-0010796 INIST</idno>
<idno type="RBID">Pascal:99-0010796</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">002F27</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Drug-induced supraglottic dystonia and spasmodic dysphonia</title>
<author>
<name sortKey="Warren, J" sort="Warren, J" uniqKey="Warren J" first="J." last="Warren">J. Warren</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Neurology, Royal Adelaide Hospital</s1>
<s2>Adelaide, South Australia</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Thompson, P" sort="Thompson, P" uniqKey="Thompson P" first="P." last="Thompson">P. Thompson</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Neurology, Royal Adelaide Hospital</s1>
<s2>Adelaide, South Australia</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint>
<date when="1998">1998</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Benzamide derivatives</term>
<term>Case study</term>
<term>Chemotherapy</term>
<term>Dystonia</term>
<term>Elderly</term>
<term>Female</term>
<term>Glottis</term>
<term>Metoclopramide</term>
<term>Neuroleptic</term>
<term>Spastic dysphonia</term>
<term>Toxicity</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Dystonie</term>
<term>Glotte</term>
<term>Dysphonie spasmodique</term>
<term>Métoclopramide</term>
<term>Neuroleptique</term>
<term>Etude cas</term>
<term>Toxicité</term>
<term>Personne âgée</term>
<term>Femelle</term>
<term>Chimiothérapie</term>
<term>Benzamide dérivé</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="1">
<s0>0885-3185</s0>
</fA01>
<fA03 i2="1">
<s0>Mov. disord.</s0>
</fA03>
<fA05>
<s2>13</s2>
</fA05>
<fA06>
<s2>6</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG">
<s1>Drug-induced supraglottic dystonia and spasmodic dysphonia</s1>
</fA08>
<fA11 i1="01" i2="1">
<s1>WARREN (J.)</s1>
</fA11>
<fA11 i1="02" i2="1">
<s1>THOMPSON (P.)</s1>
</fA11>
<fA14 i1="01">
<s1>Department of Neurology, Royal Adelaide Hospital</s1>
<s2>Adelaide, South Australia</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</fA14>
<fA20>
<s1>978-979</s1>
</fA20>
<fA21>
<s1>1998</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA43 i1="01">
<s1>INIST</s1>
<s2>20953</s2>
<s5>354000071406360220</s5>
</fA43>
<fA44>
<s0>0000</s0>
<s1>© 1999 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45>
<s0>1 ref.</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>99-0010796</s0>
</fA47>
<fA60>
<s1>P</s1>
</fA60>
<fA61>
<s0>A</s0>
</fA61>
<fA64 i2="1">
<s0>Movement disorders</s0>
</fA64>
<fA66 i1="01">
<s0>USA</s0>
</fA66>
<fC02 i1="01" i2="X">
<s0>002B02U01</s0>
</fC02>
<fC02 i1="02" i2="X">
<s0>235</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE">
<s0>Dystonie</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG">
<s0>Dystonia</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA">
<s0>Distonía</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE">
<s0>Glotte</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG">
<s0>Glottis</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA">
<s0>Glotis</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE">
<s0>Dysphonie spasmodique</s0>
<s5>04</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG">
<s0>Spastic dysphonia</s0>
<s5>04</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA">
<s0>Disfonía espasmódica</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE">
<s0>Métoclopramide</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG">
<s0>Metoclopramide</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA">
<s0>Metoclopramida</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>07</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE">
<s0>Neuroleptique</s0>
<s5>08</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG">
<s0>Neuroleptic</s0>
<s5>08</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA">
<s0>Neuroléptico</s0>
<s5>08</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE">
<s0>Etude cas</s0>
<s5>16</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG">
<s0>Case study</s0>
<s5>16</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA">
<s0>Estudio caso</s0>
<s5>16</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE">
<s0>Toxicité</s0>
<s5>17</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG">
<s0>Toxicity</s0>
<s5>17</s5>
</fC03>
<fC03 i1="07" i2="X" l="GER">
<s0>Giftigkeit</s0>
<s5>17</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA">
<s0>Toxicidad</s0>
<s5>17</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE">
<s0>Personne âgée</s0>
<s5>20</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG">
<s0>Elderly</s0>
<s5>20</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA">
<s0>Anciano</s0>
<s5>20</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE">
<s0>Femelle</s0>
<s5>21</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG">
<s0>Female</s0>
<s5>21</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA">
<s0>Hembra</s0>
<s5>21</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE">
<s0>Chimiothérapie</s0>
<s5>23</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG">
<s0>Chemotherapy</s0>
<s5>23</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA">
<s0>Quimioterapia</s0>
<s5>23</s5>
</fC03>
<fC03 i1="11" i2="X" l="FRE">
<s0>Benzamide dérivé</s0>
<s5>29</s5>
</fC03>
<fC03 i1="11" i2="X" l="ENG">
<s0>Benzamide derivatives</s0>
<s5>29</s5>
</fC03>
<fC03 i1="11" i2="X" l="SPA">
<s0>Benzamida derivado</s0>
<s5>29</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE">
<s0>Homme</s0>
</fC07>
<fC07 i1="01" i2="X" l="ENG">
<s0>Human</s0>
</fC07>
<fC07 i1="01" i2="X" l="SPA">
<s0>Hombre</s0>
</fC07>
<fC07 i1="02" i2="X" l="FRE">
<s0>Muscle strié pathologie</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG">
<s0>Striated muscle disease</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA">
<s0>Músculo estriado patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE">
<s0>Système nerveux pathologie</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG">
<s0>Nervous system diseases</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA">
<s0>Sistema nervioso patología</s0>
<s5>38</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE">
<s0>Trouble neurologique</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG">
<s0>Neurological disorder</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA">
<s0>Trastorno neurológico</s0>
<s5>39</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE">
<s0>Mouvement involontaire</s0>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG">
<s0>Involuntary movement</s0>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA">
<s0>Movimiento involuntario</s0>
<s5>40</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE">
<s0>Extrapyramidal syndrome</s0>
<s5>41</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG">
<s0>Extrapyramidal syndrome</s0>
<s5>41</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA">
<s0>Extrapiramidal síndrome</s0>
<s5>41</s5>
</fC07>
<fC07 i1="07" i2="X" l="FRE">
<s0>ORL pathologie</s0>
<s5>45</s5>
</fC07>
<fC07 i1="07" i2="X" l="ENG">
<s0>ENT disease</s0>
<s5>45</s5>
</fC07>
<fC07 i1="07" i2="X" l="SPA">
<s0>ORL patología</s0>
<s5>45</s5>
</fC07>
<fC07 i1="08" i2="X" l="FRE">
<s0>Larynx pathologie</s0>
<s5>46</s5>
</fC07>
<fC07 i1="08" i2="X" l="ENG">
<s0>Larynx disease</s0>
<s5>46</s5>
</fC07>
<fC07 i1="08" i2="X" l="SPA">
<s0>Laringe patología</s0>
<s5>46</s5>
</fC07>
<fN21>
<s1>004</s1>
</fN21>
</pA>
</standard>
<server>
<NO>PASCAL 99-0010796 INIST</NO>
<ET>Drug-induced supraglottic dystonia and spasmodic dysphonia</ET>
<AU>WARREN (J.); THOMPSON (P.)</AU>
<AF>Department of Neurology, Royal Adelaide Hospital/Adelaide, South Australia/Australie (1 aut., 2 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 1998; Vol. 13; No. 6; Pp. 978-979; Bibl. 1 ref.</SO>
<LA>Anglais</LA>
<CC>002B02U01; 235</CC>
<FD>Dystonie; Glotte; Dysphonie spasmodique; Métoclopramide; Neuroleptique; Etude cas; Toxicité; Personne âgée; Femelle; Chimiothérapie; Benzamide dérivé</FD>
<FG>Homme; Muscle strié pathologie; Système nerveux pathologie; Trouble neurologique; Mouvement involontaire; Extrapyramidal syndrome; ORL pathologie; Larynx pathologie</FG>
<ED>Dystonia; Glottis; Spastic dysphonia; Metoclopramide; Neuroleptic; Case study; Toxicity; Elderly; Female; Chemotherapy; Benzamide derivatives</ED>
<EG>Human; Striated muscle disease; Nervous system diseases; Neurological disorder; Involuntary movement; Extrapyramidal syndrome; ENT disease; Larynx disease</EG>
<GD>Giftigkeit</GD>
<SD>Distonía; Glotis; Disfonía espasmódica; Metoclopramida; Neuroléptico; Estudio caso; Toxicidad; Anciano; Hembra; Quimioterapia; Benzamida derivado</SD>
<LO>INIST-20953.354000071406360220</LO>
<ID>99-0010796</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002F27 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 002F27 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:99-0010796
   |texte=   Drug-induced supraglottic dystonia and spasmodic dysphonia
}}
Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024